Segment Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$791K Sell
1,578
-325
-17% -$156K 0.04% 191
2026
Q1
$935K Buy
1,903
+315
+20% +$171K 0.05% 172
2025
Q4
$920K Buy
1,588
+135
+9% +$76.3K 0.05% 176
2025
Q3
$705K Sell
1,453
-106
-7% -$49.3K 0.04% 188
2025
Q2
$632K Sell
1,559
-141
-8% -$59K 0.04% 187
2025
Q1
$846K Sell
1,700
-129
-7% -$69.9K 0.06% 163
2024
Q4
$952K Sell
1,829
-4,100
-69% -$2.25M 0.06% 153
2024
Q3
$3.67M Buy
5,929
+116
+2% +$68.7K 0.25% 75
2024
Q2
$3.21M Buy
5,813
+471
+9% +$270K 0.24% 78
2024
Q1
$3.1M Buy
5,342
+964
+22% +$541K 0.24% 82
2023
Q4
$2.32M Sell
4,378
-406
-8% -$197K 0.21% 85
2023
Q3
$2.42M Buy
4,784
+583
+14% +$311K 0.25% 80
2023
Q2
$2.19M Sell
4,201
-78
-2% -$42.1K 0.23% 84
2023
Q1
$2.47M Sell
4,279
-22
-0.5% -$12.4K 0.28% 75
2022
Q4
$2.37M Sell
4,301
-92
-2% -$48.7K 0.27% 78
2022
Q3
$2.23M Buy
4,393
+129
+3% +$72.2K 0.28% 79
2022
Q2
$2.32M Sell
4,264
-422
-9% -$232K 0.29% 73
2022
Q1
$2.77M Buy
4,686
+68
+1% +$39.1K 0.29% 79
2021
Q4
$3.08M Buy
4,618
+332
+8% +$207K 0.32% 75
2021
Q3
$2.45M Buy
4,286
+2
+0% +$1.1K 0.29% 82
2021
Q2
$2.16M Sell
4,284
-1
-0% -$472 0.26% 89
2021
Q1
$1.96M Buy
4,285
+223
+5% +$106K 0.26% 88
2020
Q4
$1.89M Buy
4,062
+1,603
+65% +$752K 0.27% 84
2020
Q3
$1.09M Buy
2,459
+859
+54% +$355K 0.18% 98
2020
Q2
$580K Sell
1,600
-100
-6% -$33.5K 0.11% 120
2020
Q1
$482K Buy
1,700
+610
+56% +$192K 0.11% 120
2019
Q4
$354K Buy
1,090
+18
+2% +$5.46K 0.06% 177
2019
Q3
$312K Hold
1,072
0.06% 164
2019
Q2
$315K Hold
1,072
0.06% 154
2019
Q1
$293K Sell
1,072
-113
-10% -$28.1K 0.06% 162
2018
Q4
$265K Sell
1,185
-118
-9% -$27.7K 0.07% 150
2018
Q3
$318K Buy
+1,303
New +$300K 0.07% 160

Other funds holding TMO

Segment Wealth Management's TMO Position: Q2 2026 in Review

Segment Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 17% in Q2 2026, selling an estimated $156K and leaving 1,578 shares worth $791K. The position accounts for 0.04% of the portfolio, ranked #191.

Segment Wealth Management first reported a position in TMO in Q3 2018 and has held it in 32 quarters since. The position peaked at $3.67M in Q3 2024. 577 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Segment Wealth Management held 1,578 shares of Thermo Fisher Scientific worth $791K as of Q2 2026.
  • Segment Wealth Management sold 325 Thermo Fisher Scientific shares in Q2 2026, an estimated $156K.
  • Thermo Fisher Scientific made up 0.04% of Segment Wealth Management's portfolio in Q2 2026, its #191 holding.
  • Segment Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 32 quarters since.
  • Segment Wealth Management's Thermo Fisher Scientific position peaked at $3.67M in Q3 2024.
  • 577 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Segment Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.